CD28 and uveitis: Together, these data show that in eyes with uveitis the majority of CD4+, and to a lesser extent CD8+, T cells express the costimulatory receptors CD28 and ICOS, and treatment with acazicolcept provides significant blockade of these receptors on ocular infiltrating T cells.